Why did CVS stock fall today?

Shares dropped after CMS signaled a near-flat 0.09% increase to 2027 Medicare Advantage rates, well below the 4%–6% many expected. That outlook pressures 2027 margins and could force plan repricing. The sector sold off as investors reassessed earnings risk for MA-heavy insurers, including CVS’s Aetna unit.

What are Medicare Advantage rates and why do they matter to CVS?

Medicare Advantage rates are payments CMS makes to insurers for covering Medicare beneficiaries. They drive revenue and profitability for MA plans. A near-flat update for 2027 limits pricing power and can compress margins, which matters for CVS due to its Aetna Medicare Advantage exposure and bid planning.

What should investors watch next for CVS stock?

Key items are the February 10 earnings call, management’s 2027 bid assumptions, commentary on billing accuracy changes, and April’s final CMS rates. Also watch volume trends, 50-day and 200-day moving averages, and whether cost actions or pricing updates offset lower rate expectations.

Is the dividend at risk after today’s move?

The trailing yield is about 3.19%. While the payout ratio appears manageable on trailing figures, future sustainability depends on 2026 earnings, cash flow, and the final April CMS outcome. Monitor guidance on free cash flow, debt priorities, and any capital allocation changes before drawing firm conclusions.

Global Market Insights

CVS Stock Today: January 27 Selloff on Flat Medicare Advantage Rates

ByHuzaifa Zahoor January 27, 2026January 27, 2026

CVS stock dropped 12.2% to $72.88 on January 27 after CMS signaled a near‑flat 0.09% increase to 2027 Medicare Advantage rates, far below the 4%–6% Wall Street expected. The health insurers selloff reflects worries about margins and plan pricing, with investors eyeing billing accuracy changes and final rates due in early April. Shares of CVS (CVS) slid alongside peers as traders recalibrated earnings risk. Early reports highlighted the proposal’s sting for MA-heavy insurers source.